Protein FDR Confidence: CombinedAccessionDescriptionExp. q-value: CombinedSum PEP ScoreCoverage [%]# Peptides# PSMs# Unique Peptides# AAsMW [kDa]calc. pI# Peptides (by Search Engine): A2 Sequest HT (293 IgG)# Peptides (by Search Engine): B2 Sequest HT (293 Sel1L KO)# Peptides (by Search Engine): C2 Sequest HT (293 WT)# Peptides (by Search Engine): D2 Sequest HT (293 H KO)# PSMs (by Search Engine): A2 Sequest HT (293 IgG)# PSMs (by Search Engine): B2 Sequest HT (293 Sel1L KO)# PSMs (by Search Engine): C2 Sequest HT (293 WT)# PSMs (by Search Engine): D2 Sequest HT (293 H KO)Abundance: F1: Sample, 293 IgGAbundance: F2: Sample, 293 Sel1L KOAbundance: F3: Sample, 293 WTAbundance: F4: Sample, 293 H KOAbundances Count: F1: Sample, 293 IgGAbundances Count: F2: Sample, 293 Sel1L KOAbundances Count: F3: Sample, 293 WTAbundances Count: F4: Sample, 293 H KOModificationsBiological ProcessCellular ComponentMolecular FunctionPfam IDsEntrez Gene IDEnsembl Gene IDGene SymbolChromosomeReactome PathwaysKEGG Pathways# Razor Peptides
MediumP42771Cyclin-dependent kinase inhibitor 2A OS=Homo sapiens OX=9606 GN=CDKN2A PE=1 SV=20.0321.3971111115616.55.811188438741cell organization and biogenesis;metabolic process;regulation of biological process;response to stimuluscytoplasm;cytosol;nucleuscatalytic activity;enzyme regulator activity;protein binding;RNA binding"Pf12796, Pf13637, Pf13857"1029ENSG00000147889.17CDKN2A9Cyclin D associated events in G1; Oncogene Induced Senescence; Senescence-Associated Secretory Phenotype (SASP); Oxidative Stress Induced SenescenceViral carcinogenesis; Pancreatic cancer; MicroRNAs in cancer; Chronic myeloid leukemia; Non-small cell lung cancer; Pathways in cancer; Glioma; Melanoma; HTLV-I infection; p53 signaling pathway; Bladder cancer; Cell cycle; Endocrine resistance; Platinum drug resistance0

[View entry in the full dataset]